China Pharma Holdings Inc. (CPHI)
NYSE: CPHIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CPHI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $18.86M
- EPS (TTM)
- -$0.42
- Dividend yield
- None
- 52-week range
- 0.38 – 19.19
- Day range
- 0.4384 – 0.4852
- Volume / Avg
- 32.83K / 1.60M
- Beta
- —
- Shares outstanding
- 43.02M
52-week range
CPHI stock today
On Nov 20, CPHI ended the session at $0.4384, shedding $0.0655 (13.00%), versus the S&P 500's 3.70% decline. Trading was light, with 32.83K shares changing hands, about 2% of the average daily volume. At this level, CPHI sits near the bottom of its 52-week range of $0.38 to $19.19: 97.7% below the high, set on Jul 21, 2026 and 15.4% above the low.
CPHI is down 63.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 72.6%. China Pharma has posted a net loss over the last twelve months (EPS of -$0.42), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About China Pharma
Company profileChina Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Ms. Zhilin Li
- Headquarters
- Haikou
- Employees
- 215
- Website
- chinapharmaholdings.com
Financial highlights
Full financialsIn fiscal 2025, China Pharma generated $4.1 million in revenue, down 8.5% from fiscal 2024, its first annual decline since 2024. China Pharma reported a net loss of $3.2 million, compared with a loss of $4.7 million a year earlier. Gross margin was -3.2% (up from -43.8%) and operating margin -78.2%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $4.14M | $4.53M | $7.01M | $8.10M | $9.64M |
| Growth | -8.49% | -35.41% | -13.48% | -15.95% | -11.27% |
| Net income | $-3.19M | $-4.74M | $-3.08M | $-3.97M | $-3.40M |
| EPS (diluted) | $-0.74 | $-2.71 | $-0.91 | $-3.78 | $-0.74 |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 18, 2026
- EPS actual vs est.
- $-0.17 vs —
China Pharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| COCPCocrystal Pharma Inc. | 0.95 | -2.05% | $18.30M | vs CPHI |
| MRKRMarker Therapeutics Inc. | 1.09 | -17.42% | $18.17M | vs CPHI |
| IGCIGC Pharma Inc. | 0.168 | -8.70% | $19.60M | vs CPHI |
| TXMDTherapeuticsMD Inc. | 1.71 | -5.52% | $19.79M | vs CPHI |
| ACETAdicet Bio Inc. | 2.14 | -13.01% | $20.03M | vs CPHI |
| RNAZTransCode Therapeutics Inc. | 1.16 | -10.77% | $20.07M | vs CPHI |
| KTTAPasithea Therapeutics Corp. | 0.4787 | -0.48% | $17.59M | vs CPHI |
| AARDAardvark Therapeutics Inc. | 0.9226 | -7.74% | $20.20M | vs CPHI |
Indexes, lists and sector
China Pharma stock FAQ
What is China Pharma's stock price today?
CPHI last traded at $0.4384 as of Nov 20, 4:00 PM EST, down 13.00% on the day. Prices are delayed at least 15 minutes.
Does China Pharma pay a dividend?
No. China Pharma does not currently pay a regular cash dividend.
Who is China Pharma's CEO?
Ms. Zhilin Li is the chief executive officer of China Pharma Holdings Inc., which has about 215 employees.
Has CPHI ever split its stock?
Yes. The most recent CPHI stock split was a 1-for-10 split on Apr 15, 2025, one of 4 splits on record.
What is the CPHI 52-week high?
The 52-week high for CPHI is $19.19 and the 52-week low is $0.38. The stock is currently 97.7% below its high.